If you plan to use machine learning for research, consider ChatGPT’s shortcomings and inquire about AI tools’ training data ...

Venture capitalists and private equity groups generally hold investments in such firms—seed, series A, and series B ...

Since President Donald J. Trump took office a second time on Jan. 20, leaders across the biotechnology and pharmaceutical ...

Countries can’t agree on how to share and compensate for pathogen data Global pandemic treaty nears adoption, but key ...

It’s hard nowadays for any big company to distance itself from artificial intelligence and its subset, machine learning. Drug services firms are no exception. These technologies are slowly ...